John A Balacko, MD | |
1624 Pacific Ave Ste B, Natrona Heights, PA 15065-2145 | |
(724) 226-3345 | |
(724) 226-2415 |
Full Name | John A Balacko |
---|---|
Gender | Male |
Speciality | Interventional Cardiology |
Experience | 40 Years |
Location | 1624 Pacific Ave Ste B, Natrona Heights, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942269311 | NPI | - | NPPES |
3810008241 | Medicaid | WV | |
0014154670004 | Medicaid | PA | |
2745579 | Medicaid | OH | |
0014154670007 | Medicaid | PA |
Facility Name | Location | Facility Type |
---|---|---|
Allegheny Valley Hospital | Natrona, PA | Hospital |
Forbes Hospital | Monroeville, PA | Hospital |
West Penn Hospital | Pittsburgh, PA | Hospital |
Allegheny General Hospital | Pittsburgh, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Allegheny Clinic | 5395649586 | 1941 |
News Archive
Before a woman gets pregnant it is very common for her to plan and prepare for her child's arrival to ensure that the baby will benefit from the healthiest, most comfortable life possible. Sometimes, these preparations may be financial or they may involve taking such important healthcare steps as quitting smoking. Now, according to data from the Swedish Medical Birth Register, one of the best things that a mother can do for the health of her child is to ensure that she is at a healthy weight.
Researchers writing in the journal The Lancet suggest further research that is urgently needed for effective non-antibiotic treatments for acne, because of concerns regarding long-term antibiotic use and its contribution to bacterial resistance. Pharmacies are well stocked with a wide range of acne medications. However, evidence regarding their efficacy and which treatments work best for whom are limited, the authors added.
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery products, announced today that that the U.S. Food and Drug Administration (FDA) has granted orphan drug status to P140K methylguanine methyltransferase (MGMT) transduced human CD34 cells for bone marrow protection in the treatment of glioblastoma multiforme.
Velocity Pharmaceutical Development, LLC ("VPD") and Tigercat Pharma, Inc., ("Tigercat") announced today the submission of an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for VPD-737 for the treatment of chronic pruritus.
› Verified 2 days ago
Entity Name | Allegheny Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073081493 PECOS PAC ID: 5395649586 Enrollment ID: O20040310000602 |
News Archive
Before a woman gets pregnant it is very common for her to plan and prepare for her child's arrival to ensure that the baby will benefit from the healthiest, most comfortable life possible. Sometimes, these preparations may be financial or they may involve taking such important healthcare steps as quitting smoking. Now, according to data from the Swedish Medical Birth Register, one of the best things that a mother can do for the health of her child is to ensure that she is at a healthy weight.
Researchers writing in the journal The Lancet suggest further research that is urgently needed for effective non-antibiotic treatments for acne, because of concerns regarding long-term antibiotic use and its contribution to bacterial resistance. Pharmacies are well stocked with a wide range of acne medications. However, evidence regarding their efficacy and which treatments work best for whom are limited, the authors added.
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery products, announced today that that the U.S. Food and Drug Administration (FDA) has granted orphan drug status to P140K methylguanine methyltransferase (MGMT) transduced human CD34 cells for bone marrow protection in the treatment of glioblastoma multiforme.
Velocity Pharmaceutical Development, LLC ("VPD") and Tigercat Pharma, Inc., ("Tigercat") announced today the submission of an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for VPD-737 for the treatment of chronic pruritus.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
John A Balacko, MD 1624 Pacific Ave Ste B, Natrona Heights, PA 15065-2145 Ph: (724) 226-3345 | John A Balacko, MD 1624 Pacific Ave Ste B, Natrona Heights, PA 15065-2145 Ph: (724) 226-3345 |
News Archive
Before a woman gets pregnant it is very common for her to plan and prepare for her child's arrival to ensure that the baby will benefit from the healthiest, most comfortable life possible. Sometimes, these preparations may be financial or they may involve taking such important healthcare steps as quitting smoking. Now, according to data from the Swedish Medical Birth Register, one of the best things that a mother can do for the health of her child is to ensure that she is at a healthy weight.
Researchers writing in the journal The Lancet suggest further research that is urgently needed for effective non-antibiotic treatments for acne, because of concerns regarding long-term antibiotic use and its contribution to bacterial resistance. Pharmacies are well stocked with a wide range of acne medications. However, evidence regarding their efficacy and which treatments work best for whom are limited, the authors added.
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery products, announced today that that the U.S. Food and Drug Administration (FDA) has granted orphan drug status to P140K methylguanine methyltransferase (MGMT) transduced human CD34 cells for bone marrow protection in the treatment of glioblastoma multiforme.
Velocity Pharmaceutical Development, LLC ("VPD") and Tigercat Pharma, Inc., ("Tigercat") announced today the submission of an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for VPD-737 for the treatment of chronic pruritus.
› Verified 2 days ago
Dr. Darrell W. Petz, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 1621 Union Ave, Natrona Heights, PA 15065 Phone: 724-224-6700 Fax: 724-224-8005 | |
Dr. Catherine L Eagon, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1719 Union Ave, Natrona Heights, PA 15065 Phone: 724-226-2128 Fax: 724-226-2498 | |
Edward L Malloy, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1604 Burtner Rd, Natrona Heights, PA 15065 Phone: 724-230-3030 Fax: 724-230-3001 | |
Dr. Rakesh Kumar, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1629 Union Ave, Suite 2, Natrona Heights, PA 15065 Phone: 724-224-8850 Fax: 206-339-2691 | |
Dominick Defrances, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1719 Union Ave, Natrona Heights, PA 15065 Phone: 724-226-2128 | |
Dr. Christine Sekula Crocker, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1621 Union Ave Ste C, Natrona Heights, PA 15065 Phone: 724-224-6700 Fax: 724-224-8005 | |
Molakalmuru Vamadevamurthy, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1719 Union Ave, Suite A, Natrona Heights, PA 15065 Phone: 724-226-2128 Fax: 724-226-2498 |